Botanicals

Ashwagandha Extract

Withania somnifera root extract used in stress-management and adaptogen-positioned ranges.

View options with Ashwagandha Extract Browse ingredients Order samples

The Launch Loop

1 Select
2 Review
3 Sample
4 Approve
5 Produce
6 Deliver

Why brands use it

Why brands use Ashwagandha Extract

Ashwagandha Extract is a botanical extract reviewed against the target market’s botanical rules, sitting in the botanicals family. On DAT Supply briefs it is most often considered for Calm/stress gummies and Sleep stacks — the exact positioning is set by the brand brief and reviewed against the target market’s claim rules. Editorially we frame it around Botanical with traditional use; applicable claims framework botanical claims are pending, using only applicable claims framework- or DSHEA-compatible wording for the final pack copy. Format-wise we have considered Ashwagandha Extract for gummies, capsule, softgel, powder and drops; the per-format formulation notes below describe the live constraints (taste, payload, stability, packaging) we tune in the formulation pass. Sourcing form (extract ratio for botanicals, salt or chelate form for minerals, free-form vs ester for amino acids) is reviewed against the brief, with documentation matched to the target market’s import rules. Inclusion rate and claim wording are reviewed per project — no two briefs land on the same combination, and we don’t publish off-the-shelf doses.

Supported formats

Formats this ingredient is reviewed for

DAT Supply covers gummy, capsule, softgel, tablet, powder, oral strip, liquid drop, shot, jelly and pet formats. The list below reflects every format this ingredient is reviewed for — chips link through to the manufacturing hub for each format. Final compatibility, dose and matrix are confirmed per project.

Format suitability reviewed per project.

How we use Ashwagandha Extract in formulas

A public-safe formulation reference — how this active behaves in our formats, common pairings and handling notes. Final formulation, dose and on-pack copy are confirmed per project.

Heat stable: Limited — use coated forms
Soluble in matrix: Conditional
Vegan supply: Project-specific

Format compatibility

Per-format formulation notes

Safe-baseline considerations for each format this ingredient is reviewed for. Final formulation, dose and on-pack copy are confirmed per project.

Gummies

In a pectin- or gelatin-based gummy matrix, Ashwagandha Extract is reviewed for heat stability through the cooking step, dispersibility across the dosed mass, and any flavour interaction with the cooked base. Coated or encapsulated forms may be considered when the raw active would shift taste or colour outside the target window. Per-gummy payload, daily serving count and the resulting label claim are tuned against the brand’s pack architecture. Pectin and gelatin behave differently for moisture migration and shelf-life — the matrix choice is reviewed per project alongside the active’s sensitivity to acidity, light and oxygen. Where a high inclusion rate would compromise gummy texture, we split the load across two pieces or move to a denser format. Final dosing and matrix selection are confirmed per project.

Capsules

In a two-piece capsule format Ashwagandha Extract is reviewed for fit against the chosen capsule size, the blend’s bulk density and flow, and any excipient set needed for stable filling. Shell choice (gelatin vs HPMC for vegan ranges) is tuned against the active’s moisture sensitivity and the brand’s diet positioning. Capsules carry medium-to-high payloads and let the brand split a multi-active stack across one or two daily servings, with the daily serving count reviewed per project. Where the active is hygroscopic or has a strong odour, we may pre-coat or granulate before filling. Final excipient set, capsule size and per-serving load are confirmed per project.

Softgels

In a softgel format Ashwagandha Extract must be oil-soluble or oil-dispersible; water-loving actives sit on the gummy or capsule route instead. The fill carrier (a refined oil or a co-solubilising system) is reviewed against the active’s oxidation profile and shelf-life targets, with antioxidant load tuned where the active is prone to oxidation. Shell choice (gelatin vs non-gelatin for vegan ranges) is set against the brand’s diet positioning, and the shell-fill interaction is reviewed for water migration. Softgel size and per-piece fill weight are tuned against the target dose — reviewed per project alongside the brand’s daily serving plan and pack format.

Powders

In a powder format Ashwagandha Extract is reviewed for flow, bulk density and blend uniformity, plus dispersibility and taste on reconstitution. Hygroscopic actives may need a desiccant, a moisture-barrier pouch, or an aluminium-laminate tub liner. Powder lets the brand carry the highest per-serving payloads of any DAT format, which can suit collagen-, protein- or electrolyte-positioned ranges. Pack format (tub, sachet, stick) is set against the daily serving plan and the brand’s shopper context — at-home tubs vs on-the-go sticks. Particle size, sweetener / acidulant balance and any flow aid are tuned per project to land the target sensory window.

Liquid drops

In a liquid-drop format Ashwagandha Extract must be soluble or stably dispersible in the chosen carrier (water, glycerin, oil or a mixed system). Taste masking, preservation, pH window and shelf-life targets are reviewed against the active’s sensitivity profile. Bottle and dropper geometry are matched to the target per-drop dose, with serving accuracy validated through the dropper’s drop-volume specification. Liquids carry sensitive actives well but require a tighter shelf-life and packaging plan than dry formats. Where the active is light-sensitive, amber glass or barrier-tinted PET is reviewed against the run plan. Preservation system and pH are set per project.

US structure-function statements

Structure-function wording for this ingredient is reviewed per project against DSHEA (21 USC §343(r)(6)). No final on-pack copy is implied by this page.

Structure-function statements must appear with the FDA disclaimer in the same field of vision on the label. % Daily Value (DV) based on FDA 21 CFR 101.9.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Claim framework

Botanical actives like Ashwagandha Extract sit in a partially-harmonised EU claims position: most botanical health claims remain on hold (the "on-hold list"), and country-level rules (Italy, France, Spain, Belgium) layer on top with their own positive and negative lists for botanical use. Novel-food status is checked before any brief moves forward, alongside any traditional-use route where it applies. UK rules track EU wording post-Brexit but the GB market follows its own retained list. For the US market, structure-function wording under DSHEA applies, with the FDA disclosure on pack. Pack copy is rewritten per market and reviewed per project.

Dose anchor

Typical anchor: mg per serving — confirmed per project.

Ashwagandha Extract is measured by weight (mg) per serving on DAT Supply briefs. The working anchor — the inclusion rate against which target-market claim wording is reviewed — is set during the formulation pass for each project rather than published as a fixed number on the public page. Final per-serving load depends on the chosen format (gummy payload window, capsule fill weight, softgel oil load, sachet or powder scoop size, oral-liquid bottle geometry) and the claim wording the brand needs to support against the target market. Sourcing form (extract ratio, standardised marker, micronised vs granular, salt or chelate form) is reviewed in the same pass. Country-level upper limits (France, Italy, Belgium for the EU; California Prop 65 for the US) are checked before any inclusion rate is finalised. Dose is confirmed per project — we don’t publish off-the-shelf dose tables for any active in the catalogue.

Formulas